SALMAN, A. Et Al. 2019. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data. DERMATOLOGIC THERAPY , vol.32, no.4 .

SALMAN, A., DEMİR, G., & Bekiroglu, N., (2019). The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data. DERMATOLOGIC THERAPY , vol.32, no.4.

SALMAN, ANDAÇ, GİZEM DEMİR, And GÜLNAZ NURAL BEKİROĞLU. "The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data," DERMATOLOGIC THERAPY , vol.32, no.4, 2019

SALMAN, ANDAÇ Et Al. "The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data." DERMATOLOGIC THERAPY , vol.32, no.4, 2019

SALMAN, A. DEMİR, G. And Bekiroglu, N. (2019) . "The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data." DERMATOLOGIC THERAPY , vol.32, no.4.

@article{article, author={ANDAÇ SALMAN Et Al. }, title={The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data}, journal={DERMATOLOGIC THERAPY}, year=2019}